Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 104 Show results per page	View Search Criteria \| Help With Results

Last Modified: 8/17/2004 First Published: 4/23/2003


1.		Phase II/III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) With Versus Without Etoposide in Older Patients With Diffuse Large B-Cell or Peripheral T-Cell Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				70 and over				Other				EORTC-20991 NCT00060385

Last Modified: 3/8/2005


2.		Phase III Randomized Study of Standard Chemotherapy vs High-Dose Chemotherapy with Hematopoietic Rescue Using Purged vs Unpurged AuBM or PBSC in Adults with Poor-Risk Relapsed Follicular non-Hodgkin's Lymphoma (Summary Last Modified 03/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 65								MRC-ECUP EU-93009

Last Modified: 5/4/2007


3.		Phase III Randomized Study of Sequential Treatment with 3 Noncross-Resistant Chemotherapy Combinations or Standard Chemotherapy for Poor-Prognosis Intermediate Grade and Immunoblastic non-Hodgkin's Lymphoma: IDA/CDDP/ARA-C/MePRDL, IDA/VCR/BLEO/CTX/MePRDL, and IFF/DHAD/VP-16 vs Standard CHOP (Summary Last Modified 09/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				over 15				NCI				MDA-DM-94017 NCI-T94-0040D, NCT00002565, T94-0040

Last Modified: 9/29/2008 First Published: 6/1/1996


4.		Phase III Randomized International Study of Reduction in Intensification of the LMB 89 Regimen for non-Hodgkin's Lymphoma: Reduced Doses of CTX for Intermediate-Risk Patients and Less Maintenance Therapy for Intermediate-Risk and High-Risk Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 6 months to under 21				NCI				COG-C5961 CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, NCT00002757

Last Modified: 8/10/2006


5.		Phase III Randomized Study of Induction With the ALL-2 Regimen (Cytarabine and High-Dose Mitoxantrone Based) Versus the L-20 Regimen (Vincristine and Prednisone Based) in Adults With Acute Lymphoblastic Malignancy: The ALL-4 Protocol

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				MSKCC-96015A1 NCI-V96-0881, NCT00002766

Last Modified: 3/10/2004


6.		Phase III Randomized Study of High-Dose Sequential Chemotherapy Followed by Peripheral Blood Stem Cell Transplantation vs Cyclophosphamide/Doxorubicin/Vincristine/Prednisone (CHOP) for Poor-Risk, Intermediate- and High-Grade Non-Hodgkin's Lymphoma (Summary Last Modified 02/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 to 65				NCI				E-2493 E2493

Last Modified: 8/2/2007 First Published: 1/1/1998


7.		Phase III Randomized Study of CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) With or Without Rituximab in Older Patients With Diffuse Mixed, Diffuse Large, or Immunoblastic Large Cell Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				60 and over				NCI				ECOG-E4494 E4494, CLB-9793, SWOG-E4494, NCT00003150

Last Modified: 11/28/2006 First Published: 4/1/1998


8.		Phase III Randomized Study of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Versus Sequential High-Dose Chemotherapy With Autologous Peripheral Blood Stem Cell Transplantation in Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 60				Other				SWS-SAKK-38/97 EU-97037, NCT00003215

Last Modified: 5/21/2007 First Published: 12/1/1998


9.		Phase III Randomized Study of High Dose Chemotherapy and Autologous Bone Marrow Transplantation as Initial Therapy for Poor Risk Intermediate and High Grade Adult Non-Hodgkin's Lymphoma (Summary Last Modified 05/2002)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 to 65								BNLI-LY02 EU-98039, NCT00003578

Last Modified: 5/25/2007 First Published: 12/1/1998


10.		Phase III Randomized Study of CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) With or Without Rituximab in Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				Over 18				NCI				AMC-010 CPMC-IRB-9691, CWRU-AMC-1400, UCLA-9810029, NCT00003595

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute